Trials
Search / Trial NCT05641597

Functional Impact of Reconstructive Surgery by Harvesting a Vascularized Free Fibula Flap Postoperatively.

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Dec 5, 2022

Trial Information

Current as of January 14, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a specific surgery called free fibula flap reconstruction, which uses a piece of bone from the leg to help repair complex areas in the face after cancer or injury. The researchers want to understand how this surgery impacts patients' movement and quality of life in the short term (one month after surgery) and medium term (six months after surgery). They aim to identify any difficulties patients might face, such as pain or problems walking, so they can create better rehabilitation programs tailored to individual needs.

To participate in this study, you need to be at least 18 years old and scheduled for this type of surgery at the Dijon University Hospital. You should also be willing to follow the study requirements and provide informed consent. Over about seven months, participants will have three scheduled visits to assess their recovery and overall well-being. This study is important because it will provide valuable information that can help improve recovery strategies for patients undergoing this type of surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients eligible for bone reconstruction with a free fibula flap
  • Age ≥ 18 years
  • Procedure scheduled in the plastic and maxillofacial surgery department of the Dijon University Hospital
  • Willingness to comply with the protocol requirements
  • Person having given oral, free and informed consent
  • Exclusion Criteria:
  • Person who is not affiliated or not a beneficiary of a social security system
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a legal protection measure
  • Pregnant, parturient or breastfeeding woman
  • Major who is incapable or unable to give oral consent
  • Minor
  • Indication for bone reconstruction of a lower limb (e.g. femur) or pelvis
  • Musculoskeletal or neurological disorders causing significant prior impairment of walking (whatever the etiology)
  • Cognitive disorders that prevent the proper understanding of instructions and the completion of questionnaires
  • Non operated patient

About Centre Hospitalier Universitaire Dijon

The Centre Hospitalier Universitaire Dijon (CHU Dijon) is a leading academic medical institution in France, dedicated to advancing healthcare through innovative research and clinical trials. With a focus on patient-centered care, CHU Dijon integrates comprehensive medical services with cutting-edge research initiatives across various specialties. The institution is committed to enhancing clinical outcomes and improving health standards by facilitating rigorous scientific investigations and collaborations with national and international partners. By prioritizing ethical practices and adherence to regulatory standards, CHU Dijon aims to contribute significantly to the development of new therapies and medical technologies.

Locations

Dijon, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials